Attana and Triolab sign MOU on distribution of Attana's diagnostic offer

Attana can today announce that the company has signed an MOU (“Memorandum of Understanding”) with Triolab AB regarding marketing and sales of Attana's analytical instruments and diagnostic kits in the Nordic region.

About Triolab:
Triolab AB is Sweden's largest independent distributor of laboratory diagnostics with more than 35 years of market experience. Together with their sister companies in the rest of the Nordic and Baltic regions, sales exceed SEK 1 billion. Triolab is wholly owned by AddLife, a Swedish company listed on Nasdaq Stockholm since 2016.

About the agreement:
The MOU does not contain financial commitments but enables the parties to immediately present a joint solution to potential customers and lays the foundation for a future distribution agreement where Triolab together with Attana markets and sells Attana's products.

Attana's CEO, Teodor Aastrup comments:

“Triolab is an ideal distribution partner and well positioned to help Attana reach out with our unique technology in the Nordic diagnostics market. We are now looking forward to receiving our first CE-IVD certification, and together with Triolab, commercialize Attana's offer within advanced COVID-19 diagnostics.”

Triolab's CEO, Fredrik Brandt adds:

"We have been following the development of Attana's diagnostic solutions and see great potential to offer customers innovative immunity tests together with Attana, as a complement to our already strong market position within COVID-19 diagnostics."

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Tags:

Subscribe

Media

Media

Documents & Links